Andrés Tittarelli

9PUBLICATIONS
13CO-AUTHORS
Innate immunityPredictive and prognostic markersGene and molecular therapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 25, 2026
Early neutrophil infiltration promotes TRIMELVax-induced antitumor immunity by linking local inflammation to tumor control.

|Jun 12, 2026
Toll-like Receptor 3 as a Context-Dependent Molecular Switch in Epithelial Cancers: Balancing Cell Death and Tumor-Supportive Programs.

|Dec 24, 2025
PLGA Nanoencapsulation Enhances Immunogenicity of Heat-Shocked Melanoma Tumor Cell Lysates.

Kevin Calderón Matheu, Benjamín Cáceres Araya, Fiorella Tarkowski Diaz

|May 30, 2025
Tumor hypoxia shapes natural killer cell anticancer activities.

Mauricio A Retamal, Flavio Salazar-Onfray, Fermín E González

|Apr 27, 2024
Long-Term Survival and Immune Response Dynamics in Melanoma Patients Undergoing TAPCells-Based Vaccination Therapy.

Andrés Tittarelli, Cristian Pereda, María A Gleisner

|Jul 14, 2023
Co-Expression of Immunohistochemical Markers MRP2, CXCR4, and PD-L1 in Gallbladder Tumors Is Associated with Prolonged Patient Survival.

Andrés Tittarelli, Omar Barría, Evy Sanders

Pageof 2

Frequent Collaborators

7 joint publications

Flavio Salazar-Onfray

2 joint publications

María Alejandra Gleisner

2 joint publications

Alvaro Lladser

2 joint publications

Fermín E González